An observational study was performed to analyze the efficacy, in terms of humoral response and CD4+ and CD8+ cell responses, of COVID vaccination in patients with breast cancer under treatment with CDK4/6i, in comparison to healthy controls. The gene discussed is CDK4; the disease is breast carcinoma.